Drug Development
The university researchers, whose work began more than a decade ago, engineered a high-affinity, "sticky" antibody fragment that binds to the anthrax toxin
Southern Research announced a new test that can be used by researchers worldwide to detect the virus in infected cell cultures
New understanding of how artemisinin works could facilitate development of new drugs and therapeutic strategies against malaria
Scientists peel helpful and harmful properties of a natural substance apart, harnessing the “sugar code” that lets viruses enter cells
Computational models suggest new design for nanoparticles used in targeted drug delivery
New software programs should help identify potential avenues for improved drug treatments for diabetes and other diseases
The first nanometer resolved image of individual tobacco mosaic virions shows the potential of low-energy electron holography
Work could lead to a more stable supply of the drug and allow scientists to manipulate that drug to make it even safer and more effective
SLAC's X-ray laser lends new insight into key target for drug development
A biomedical firm that traces its origins to research done at the University of Copenhagen has been acquired by an American drug maker. The sale underscores the role the University plays in the establishment of spin-out firms and in helping society benefit from research.
